THRIVENT FINANCIAL FOR LUTHERANS - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$136
-76.1%
31,474
-63.6%
0.00%
-100.0%
Q2 2023$570
-5.9%
86,427
-3.2%
0.00%0.0%
Q1 2023$606
-10.0%
89,295
-1.9%
0.00%
-50.0%
Q4 2022$673
-99.9%
91,067
-0.5%
0.00%0.0%
Q3 2022$904,000
+49.4%
91,488
+64.8%
0.00%0.0%
Q2 2022$605,000
+17.9%
55,499
+22.4%
0.00%
+100.0%
Q1 2022$513,000
-27.8%
45,354
+0.0%
0.00%0.0%
Q4 2021$711,000
-7.8%
45,339
+0.8%
0.00%
-50.0%
Q3 2021$771,000
-21.1%
44,973
-1.0%
0.00%0.0%
Q2 2021$977,000
+44.3%
45,422
+0.7%
0.00%
+100.0%
Q1 2021$677,000
+13.8%
45,085
-0.4%
0.00%0.0%
Q4 2020$595,000
+35.5%
45,270
-0.3%
0.00%0.0%
Q3 2020$439,000
-15.4%
45,4020.0%0.00%
-50.0%
Q2 2020$519,000
+12.1%
45,402
+1.6%
0.00%0.0%
Q1 2020$463,000
-33.6%
44,701
+5.3%
0.00%0.0%
Q4 2019$697,000
+24.2%
42,470
+0.4%
0.00%0.0%
Q3 2019$561,000
-3.6%
42,281
+2.4%
0.00%0.0%
Q2 2019$582,000
-21.1%
41,300
+3.0%
0.00%0.0%
Q1 2019$738,000
-23.8%
40,086
+8.1%
0.00%
-33.3%
Q4 2018$969,000
+16.5%
37,074
+2.2%
0.00%0.0%
Q3 2018$832,000
-3.9%
36,259
-61.0%
0.00%
-25.0%
Q4 2015$866,00093,0600.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Signpost Capital Advisors, LP 1,688,952$27,327,00010.37%
Palo Alto Investors LP 3,240,424$52,430,0003.90%
Parametrica Management Ltd 12,509$202,0001.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,740,400$28,160,0001.08%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 557,100$9,014,0001.07%
Westend Capital Management, LLC 64,086$841,0001.00%
WALL STREET ASSOCIATES 702,700$11,370,0000.98%
Baker Brothers Advisors 4,372,153$70,741,0000.87%
Iguana Healthcare Management, LLC 100,000$1,618,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,085,301$17,560,0000.71%
View complete list of VANDA PHARMACEUTICALS INC shareholders